Treatment intensity and survival in patients with relapsed or refractory diffuse large B-cell lymphoma in Denmark: a real-life population-based study

PURPOSE: High-dose chemotherapy with autologous stem cell transplantation (ASCT) is considered to be the only curative treatment option for patients with refractory or relapsed diffuse large B-cell lymphoma (DLBCL). Due to toxicity, not all patients are eligible for this treatment leading to differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Arboe, Bente, Olsen, Maja Halgren, Gørløv, Jette Sønderskov, Duun-Henriksen, Anne Katrine, Dalton, Susanne Oksbjerg, Johansen, Christoffer, de Nully Brown, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407517/
https://www.ncbi.nlm.nih.gov/pubmed/30881137
http://dx.doi.org/10.2147/CLEP.S178003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407517/
https://www.ncbi.nlm.nih.gov/pubmed/30881137
http://dx.doi.org/10.2147/CLEP.S178003

Ejemplares similares